ambroxol has been researched along with Cystic Fibrosis of Pancreas in 11 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The therapeutic efficacy of oral N-acetylcysteine (NAC) and ambroxol as compared with the effect of placebos was studied in 36 cystic fibrosis (CF) patients with mild to moderate pulmonary disease." | 9.05 | A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis. ( Bender, SW; Hofmann, D; Posselt, HG; Ratjen, F; Stöver, B; Wönne, R, 1985) |
| "Ambroxol, a mucokinetic anti-inflammatory drug, has been used for treatment of cystic fibrosis (CF)." | 7.79 | The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells. ( Hussain, R; Johannesson, M; Oliynyk, I; Roomans, GM; Strid, H; Varelogianni, G, 2013) |
| "The therapeutic efficacy of oral N-acetylcysteine (NAC) and ambroxol as compared with the effect of placebos was studied in 36 cystic fibrosis (CF) patients with mild to moderate pulmonary disease." | 5.05 | A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis. ( Bender, SW; Hofmann, D; Posselt, HG; Ratjen, F; Stöver, B; Wönne, R, 1985) |
| "Ambroxol, a mucokinetic anti-inflammatory drug, has been used for treatment of cystic fibrosis (CF)." | 3.79 | The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells. ( Hussain, R; Johannesson, M; Oliynyk, I; Roomans, GM; Strid, H; Varelogianni, G, 2013) |
| "Cystic fibrosis is an inherited condition resulting in thickened, sticky respiratory secretions." | 2.49 | Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. ( Nash, EF; Ratjen, F; Stephenson, A; Tam, J; Tullis, E, 2013) |
| "Cystic fibrosis is an inherited condition resulting in thickened, sticky respiratory secretions." | 2.45 | Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. ( Nash, EF; Ratjen, F; Stephenson, A; Tullis, E, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Varelogianni, G | 1 |
| Hussain, R | 1 |
| Strid, H | 1 |
| Oliynyk, I | 1 |
| Roomans, GM | 1 |
| Johannesson, M | 1 |
| Tam, J | 1 |
| Nash, EF | 2 |
| Ratjen, F | 3 |
| Tullis, E | 2 |
| Stephenson, A | 2 |
| Dhar, R | 1 |
| Sharafkhaneh, A | 1 |
| Velamuri, S | 1 |
| Badmaev, V | 1 |
| Lan, C | 1 |
| Hanania, N | 1 |
| Akkoca Yildiz, O | 1 |
| Romano, C | 1 |
| Gargani, GF | 1 |
| Minicucci, L | 1 |
| Nantron, M | 1 |
| Zapletal, A | 1 |
| Vávrová, V | 1 |
| Stefanová, J | 1 |
| Horák, J | 1 |
| Samánek, M | 1 |
| Serrano, J | 1 |
| Sanchis, J | 1 |
| Derelle, J | 1 |
| Bertolo-Houriez, E | 1 |
| Marchal, F | 1 |
| Weber, M | 1 |
| Virion, JM | 1 |
| Vidailhet, M | 1 |
| Wönne, R | 1 |
| Posselt, HG | 1 |
| Stöver, B | 1 |
| Hofmann, D | 1 |
| Bender, SW | 1 |
6 reviews available for ambroxol and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Ambroxol; Carbocysteine; Cystic Fi | 2013 |
Role of mucolytics in wet cough.
Topics: Ambroxol; Asthma; Bronchodilator Agents; Cholinergic Antagonists; Cough; Cystic Fibrosis; Expectoran | 2013 |
The potential role of natural agents in treatment of airway inflammation.
Topics: Ambroxol; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Cystic Fibrosis; Diet; Expectorants; Hu | 2007 |
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Ambroxol; Carbocysteine; Cystic Fi | 2009 |
[Ambroxol].
Topics: Ambroxol; Anti-Inflammatory Agents; Antioxidants; Asthma; Bronchial Hyperreactivity; Cystic Fibrosis | 2006 |
[Usefulness of mucoactive drugs in respiratory diseases].
Topics: Acetylcysteine; Ambroxol; Bromhexine; Bronchiectasis; Bronchitis; Cystic Fibrosis; Deoxyribonuclease | 1998 |
2 trials available for ambroxol and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
[Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience].
Topics: Acetylcysteine; Adolescent; Ambroxol; Bromhexine; Bronchial Diseases; Child; Child, Preschool; Clini | 1984 |
A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis.
Topics: Acetylcysteine; Adolescent; Adult; Ambroxol; Bromhexine; Child; Clinical Trials as Topic; Cystic Fib | 1985 |
3 other studies available for ambroxol and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
Topics: Ambroxol; Biological Transport; Blotting, Western; Bronchi; Calcium; Chlorides; Cystic Fibrosis; Cys | 2013 |
[Functional examination of the lungs in evaluating the effect of respiratory rehabilitation and mucolytics in cystic fibrosis].
Topics: Adolescent; Adult; Ambroxol; Bromhexine; Child; Cystic Fibrosis; Female; Humans; Male; Respiratory F | 1983 |
[Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
Topics: Adolescent; Adult; Ambroxol; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Deoxyr | 1998 |